leases standard (TFRS 16). Note: Excluded effect from deferred income tax TAS 32 and TFRS 9 Adopted standard Change in fair value of available-for-sales investments - Recognized loss in OCI (Other

cost The Company and its subsidiaries’ financial cost from loan and permission note were Baht 68 million or decreased from the same period of previous year by Baht 1 million due to the interest rate was

970,000 baht. Name, position and shareholding proportion of the connected persons Note: 1 Mr. Kazumasa Oshima is the Non-Executive Director of ACS Capital and Executive Director of AEONTS. However, Mr

71.93 16.05 39.39 22.83 75.73 16.64 (50.65) (70.42) Note: The ratio in the income statement is presented as a percentage of total income. The cost of sales of real estate is shown as a percentage of

financial statement of the Company and its subsidiaries as at March 31, 2020 4 Note : 1 and 2 The company inform the Stock Exchange of Thailand on 22 April 2020. No. Contract No. Borrower Lender Appro ved

Remuneration Committee* 20,000 20,000 (Baht/Person/Meeting) Member of the Nomination and Remuneration Committee * 10,000 10,000 (Baht/Person/Meeting Note : * the meeting allowance shall be paid on a per-meeting

4,119,125 The total transaction from the period October 2020 to December 2020 is the amount of 4,119,125 Baht. Name, position and shareholding proportion of the connected persons. Note: 1Mr.Kazumasa Oshima is

profit margin 2.70% 46.22% (43.52%) DOD BIOTECH PUBLIC COMPANY LIMITED 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon, Samutsakhon 74000 Page 2 * Note the financial statements for the 3rd quarter ended

# -,.) @)ก ก #A B + NF/ ## *8##(E/ก# ## E +* (non P investment grade) 70/ / ## ++* 8ก# A**8##(E (Unrated) ?*,A0+ B + NF/ ## #N #, #7G (Structured Note) ก A0( # #N #, # (Derivatives) ?*, /E 0.(- ก

Case number 269/2563 (detailed in Note to the Financial Statements No.26) 4. Financial costs, amount Baht 4.80 million, decrease Baht 2.40 million or 33.26 percent because the Company has redeemed the